Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation

Published:2019-08-20 Issue:12 Volume:66 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Friend Brian D.¹²^ORCID,Tang Kevin¹,Markovic Daniela³,Elashoff David³,Moore Theodore B.¹,Schiller Gary J.⁴

Affiliation:

1. Department of PediatricsUCLA Mattel Children's Hospital Los Angeles California

2. Department of PediatricsCenter for Cell and Gene TherapyBaylor College of MedicineTexas Children's Hospital Houston Texas

3. Department of Medicine Statistics CoreDavid Geffen School of Medicine at UCLA Los Angeles California

4. Department of MedicineDavid Geffen School of Medicine at UCLA Los Angeles California

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.27940

Reference54 articles.

1. Center for International Blood and Marrow Transplant a contractor for the C.W. Bill Young Cell Transplantation Program operated through the U. S. Department of Health and Human Services Health Resources and Services Administration Healthcare Systems Bureau.Demographics of HCT performed in the United States and reported to CIBMTR by donor type and cell source for each donor type.https://bloodcell.transplant.hrsa.gov/research/transplant_data/transplant_activity_report/index.html. Accessed September 20 2018.

2. Survival Differences between Adolescents/Young Adults and Children with B Precursor Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplantation

3. Allogeneic Hematopoietic Stem Cell Transplantation for Adolescents and Young Adults with Acute Myeloid Leukemia

4. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

5. Usefulness of the hematopoietic cell transplantation-specific comorbidity index (HCT-CI) in predicting outcomes for adolescents and young adults with hematologic malignancies undergoing allogeneic stem cell transplant

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What makes a pediatric or young adult patient an appropriate transplant candidate?;Hematology;2023-12-08

2. Evaluation of Children with Malignancies for Blood and Marrow Transplantation: A Report from the ASTCT Committee on Practice Guidelines;Transplantation and Cellular Therapy;2023-05

3. Expanded HCT-CI Definitions Capture Comorbidity Better for Younger Patients of Allogeneic HCT for Nonmalignant Diseases;Transplantation and Cellular Therapy;2023-02

4. Adapting the HCT-CI Definitions for Children, Adolescents, and Young Adults with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Cell Transplantation;Transplantation and Cellular Therapy;2023-02

5. Reduced-toxicity myeloablative conditioning regimen using fludarabine and full doses of intravenous busulfan in pediatric patients not eligible for standard myeloablative conditioning regimens: Results of a multicenter prospective phase 2 trial;Bone Marrow Transplantation;2022-08-26